BACKGROUND
The Evolut and the Navitor transcatheter heart valves (THVs) represent the most widely used self-expanding implanted valves. Despite a similar implant concept, they markedly differ in design and hemodynamic performance. In both THVs, conduction disturbances following transcatheter aortic valve replacement (T...
Enrico Poletti, O. Oliva, Ahmad Hassan et al.· Catheterization and cardiova...· 0 citations
BACKGROUND
Data on early outcomes of the novel balloon-expandable (BE) Octapro transcatheter heart valve (THV) in real-world practice are limited. We sought to assess procedural safety and early outcomes of the Octapro in patients with severe native aortic stenosis (AS) undergoing transcatheter aortic valve implantatio...
A. Ielasi, E. Moscarella, Gregor Verček et al.· International Journal of Car...· 0 citations
TTVR with the LuX-Valve Plus system to treat patients with severe or greater symptomatic TR and a large tricuspid annulus was associated with high intraprocedural and 30-day clinical success rates, significant TR reduction and functional improvement, and low permanent pacemaker implantation rates.
O. de Backer, Y. Lim, R. von Bardeleben et al.· EuroIntervention· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.